DE60002855D1 - Haloalkoxy-imidazonaphthyridine - Google Patents

Haloalkoxy-imidazonaphthyridine

Info

Publication number
DE60002855D1
DE60002855D1 DE60002855T DE60002855T DE60002855D1 DE 60002855 D1 DE60002855 D1 DE 60002855D1 DE 60002855 T DE60002855 T DE 60002855T DE 60002855 T DE60002855 T DE 60002855T DE 60002855 D1 DE60002855 D1 DE 60002855D1
Authority
DE
Germany
Prior art keywords
imidazonaphthyridine
haloalkoxy
compounds
useful
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60002855T
Other languages
English (en)
Other versions
DE60002855T2 (de
Inventor
Gerhard Grundler
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
Joerg Senn-Bilfinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of DE60002855D1 publication Critical patent/DE60002855D1/de
Publication of DE60002855T2 publication Critical patent/DE60002855T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
DE60002855T 1999-04-17 2000-04-14 Haloalkoxy-imidazonaphthyridine Expired - Fee Related DE60002855T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (2)

Publication Number Publication Date
DE60002855D1 true DE60002855D1 (de) 2003-06-26
DE60002855T2 DE60002855T2 (de) 2004-05-06

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002855T Expired - Fee Related DE60002855T2 (de) 1999-04-17 2000-04-14 Haloalkoxy-imidazonaphthyridine

Country Status (12)

Country Link
US (1) US6503923B1 (de)
EP (1) EP1173439B1 (de)
JP (1) JP2002542248A (de)
AT (1) ATE240956T1 (de)
AU (1) AU3966600A (de)
CA (1) CA2370231A1 (de)
DE (1) DE60002855T2 (de)
DK (1) DK1173439T3 (de)
ES (1) ES2199810T3 (de)
PT (1) PT1173439E (de)
SI (1) SI1173439T1 (de)
WO (1) WO2000063211A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004512338A (ja) 2000-10-25 2004-04-22 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃液分泌抑制剤としてのポリ置換イミダゾピリジン
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EE05234B1 (et) * 2001-03-08 2009-12-15 Astrazeneca Ab 6-karboksamidoimidaso[1,2-a] pridiinihendite kasutamine ravimi p?hjustatud maohaavandi v„ltimiseks
JP2005500372A (ja) 2001-08-02 2005-01-06 アルタナ　ファルマ　アクチエンゲゼルシャフト 三環エポキシド
JP2005504048A (ja) * 2001-08-03 2005-02-10 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃腸障害治療用のアルカリ置換されたイミダゾピリジン
EP1417208A1 (de) * 2001-08-03 2004-05-12 ALTANA Pharma AG Aminosubstituierte imidazopyridine für die behandlung gastrointestinaler erkrankungen
CN1633435A (zh) 2002-02-15 2005-06-29 奥坦纳医药公司 三环n－酰基化合物
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2506027A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
EP1599175A2 (de) * 2003-02-17 2005-11-30 ALTANA Pharma AG Imidazopyridin enthaltende zusammensetzungen und ihre verwendung bei der behandlung von entzündlichen magen-darm-erkrankungen
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
JP2006528231A (ja) * 2003-05-27 2006-12-14 アルタナ　ファルマ　アクチエンゲゼルシャフト プロトンポンプ阻害剤と胃腸運動性を変更する化合物との医薬品組合せ物
AU2004285394B2 (en) 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
US7326784B2 (en) 2003-12-19 2008-02-05 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
US8366735B2 (en) * 2004-09-10 2013-02-05 Penumbra, Inc. System and method for treating ischemic stroke
EP1797089A1 (de) * 2004-10-01 2007-06-20 Altana Pharma AG Substituierte tricyclische benzimidazole
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
PL193616B1 (pl) 1998-09-23 2007-02-28 Altana Pharma Ag Tetrahydropirydoetery

Also Published As

Publication number Publication date
EP1173439A1 (de) 2002-01-23
US6503923B1 (en) 2003-01-07
AU3966600A (en) 2000-11-02
DK1173439T3 (da) 2003-09-08
CA2370231A1 (en) 2000-10-26
ES2199810T3 (es) 2004-03-01
SI1173439T1 (en) 2003-10-31
EP1173439B1 (de) 2003-05-21
DE60002855T2 (de) 2004-05-06
JP2002542248A (ja) 2002-12-10
PT1173439E (pt) 2003-10-31
ATE240956T1 (de) 2003-06-15
WO2000063211A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
DE60002855D1 (de) Haloalkoxy-imidazonaphthyridine
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
ATE302775T1 (de) Carbolinderivate
CY1109219T1 (el) Ινδολο, αζαινδολο και σχετικα ετεροκυκλικα αμιδοπιπεραζινο παραγωγα
ATE346067T1 (de) Carbolinderivate
ATE332903T1 (de) Kondensierte pyridoindolderivate
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
PT1325011E (pt) Metodos e compostos para tratamento de doencas proliferativas
ATE332302T1 (de) Alkylierte imidazopyridinderivate
DE60112960D1 (de) Kondensierte pyridoindolderivate
DE60127131D1 (de) Tricyclische imidazopyridine
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
MXPA05009282A (es) Derivados de anilina sustituidos.
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
ATE259813T1 (de) Triazolopyrimidinderivate
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
DE60007120D1 (de) Isophosphoramide-senfgasanalogen und deren verwendung
ATE368649T1 (de) Cyanoguanidin prodrugs
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
SG171472A1 (en) Substituted aniline derivatives
ATE269313T1 (de) Tryptase-inhibitoren
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE

8339 Ceased/non-payment of the annual fee